Pablo F. G.
- Country
- Spain
- Department
- 1803: Dermatologia
Research Overview
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Upadacitinib in Moderate to Severe Hidradenitis Suppurativa Post Anti-TNF Therapy Failure
- Efficacy and Safety Evaluation of AVTX-009 in Moderate to Severe Hidradenitis Suppurativa: A Phase 2 Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 20 of 109 partner sites.
Specializations
Cutaneous Oncology
Focuses on malignant skin neoplasms, integrating targeted therapies and immuno‑oncology approaches.
- Advanced Melanoma
- Squamous Cell Carcinoma of the head and neck
- Basal Cell Carcinoma with high‑risk features
- Cutaneous Metastases from internal solid tumors
Research is conducted at Hospital Universitario Ramón y Cajal, leveraging multidisciplinary oncology collaborations.
Inflammatory Dermatoses
Investigates chronic inflammatory skin conditions, emphasizing immune modulation and barrier restoration.
- Atopic Dermatitis
- Psoriasis
- Vitiligo
- Bullous Pemphigoid
Studies include biologic agents and novel small‑molecule inhibitors.
Infectious and Mycobacterial Skin Disease
Explores bacterial and mycobacterial infections affecting the skin and subcutaneous tissues.
- Newly diagnosed Mycobacterium avium Complex lung infection
- Actinic Keratosis secondary to chronic UV exposure
- Candidemia with cutaneous manifestations
- Clostridioides difficile associated skin complications
Integrates antimicrobial stewardship with dermatologic assessment.
Systemic Solid Tumor Oncology
Participates in multicenter trials addressing diverse advanced solid tumors beyond cutaneous sites.
- Breast Cancer – hormone‑receptor positive
- Non‑small Cell Lung Cancer – KRAS‑mutant
- Renal Cell Carcinoma – metastatic
- Hepatocellular Carcinoma – advanced
Collaboration with oncology units enhances translational insights.
Autoimmune and Systemic Immune‑Mediated Diseases
Examines systemic autoimmune disorders with dermatologic involvement, targeting cytokine pathways.
- Systemic Lupus Erythematosus
- Dermatomyositis
- Myasthenia Gravis
- IgG4‑related disease
Therapeutic strategies include monoclonal antibodies and JAK inhibitors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.